Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the relative effectiveness and safety of diode laser cyclophotocoagulation procedure to reduce IOP and relieve pain in adult patients with refractory glaucoma.


Clinical Trial Description

A hospital -based, prospective interventional non comparative case series study.This study will be conducted on patients with refractory glaucoma whose ages are 18 years and older.They will be subjected to Transscleral Diode Laser Cyclophotocoagulation. Postoperative evaluation will be scheduled for the first day postoperative, then 1 week later and then at 1st, 3rd, month postoperative. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04921098
Study type Interventional
Source Sohag University
Contact Mina A Besada, Resident
Phone 01280899267
Email mena011205@med.sohag.edu.eg
Status Recruiting
Phase N/A
Start date July 1, 2021
Completion date April 2022

See also
  Status Clinical Trial Phase
Recruiting NCT01128699 - Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma Phase 3
Completed NCT05521334 - MicroPulse Transscleral Laser Cyclophotocoagulation With the Zig Zag Mode in Glaucoma. N/A
Recruiting NCT00349414 - Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Phase 1/Phase 2
Completed NCT01404364 - Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye N/A
Completed NCT00971061 - Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma Phase 3
Not yet recruiting NCT05230355 - Comparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory Glaucoma N/A
Completed NCT04303897 - Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma
Recruiting NCT00893490 - Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma Phase 1